Cite

HARVARD Citation

    Patrikidou, A. et al. (2017). Upfront Docetaxel in the Post-STAMPEDE World: Lessons from an Early Evaluation of Non-trial Usage in Hormone-Sensitive Prostate Cancer. Clinical oncology. 29 (10), pp. e174-e175. [Online]. 
  
Back to record